针对B7-H3的CAR-T细胞活动在固体癌症中通过放射治疗得到增强
Marco Ventin1, Giulia Cattaneo1, Luke Maggs1
1Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Frontiers in oncology
|July 24, 2023
概括
放射疗法可以增强仿真抗原受体 (CAR) T细胞治疗对固体瘤的有效性. 这种组合克服了抵抗机制,改善了CAR T细胞消除TNBC,HNSCC和PDAC等癌症的机制.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射瘤学 辐射瘤学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中取得了成功,但在固体瘤中面临挑战.
- 固体瘤具有多种抵抗机制,限制了CAR T细胞的疗效.
- 克服这些障碍对于推进CAR T细胞治疗至关重要.
研究的目的:
- 研究放射疗法在固体瘤中增强CAR T细胞疗法的潜力.
- 探索如何辐射治疗可以克服对CAR T细胞治疗的抗性.
- 评估放射治疗和B7-H3 CAR T细胞对特定固体癌症的联合作用.
主要方法:
- 文献审查和现有数据的分析.
- 放射治疗对固体瘤对CAR T细胞敏感性的影响的实验研究.
- 专注于三阴性乳腺癌 (TNBC),头角状细胞癌 (HNSCC) 和胰腺管道腺癌 (PDAC).
主要成果:
- 放射治疗增加了固体瘤 (TNBC,HNSCC,PDAC) 对B7-H3 CAR T细胞治疗的敏感性.
- 机制包括减少癌细胞的增殖和改变apoptotic分子的表达.
- 还观察到向抗原 (B7-H3) 的升调,增强了CAR T细胞的识别.
结论:
- 放射治疗可以显著提高CAR T细胞治疗在固体瘤中的疗效.
- 组合策略有望克服耐药性并增强抗瘤反应.
- 对这些结合方法的进一步研究有必要进行临床应用.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560


